Wound dressings and systems for effluent management of topical wound therapy and related methods
This disclosure includes wound dressings and systems for effluent management of topical wound therapy and related methods. Some devices, which are configured to dilute therapeutic gas effluent flowing from a dressing, comprise a therapeutic gas source configured to provide therapeutic gas to the dressing; a container comprising a sidewall that defines a chamber configured to receive therapeutic gas effluent from the dressing; a negative pressure source configured to be coupled to the container such that the negative pressure source can be activated to draw fluid from the dressing through the chamber of the container; and a diluent gas source configured to deliver a diluent gas to dilute therapeutic gas effluent before the therapeutic gas effluent enters the negative pressure source.
1. A device configured to dilute therapeutic gas effluent flowing from a dressing, the device comprising:
a therapeutic gas source configured to provide therapeutic gas to the dressing;
a first outlet configured to be in fluid communication with the therapeutic gas source;
a container comprising a sidewall that defines a chamber configured to receive the therapeutic gas effluent from the dressing;
a first inlet configured to be in fluid communication with the chamber and to receive the therapeutic gas effluent from the dressing;
a negative pressure source configured to be coupled to the container such that the negative pressure source can be activated to draw fluid from the dressing through the chamber of the container, wherein the negative pressure source comprises:
an inlet through which gas is received into the negative pressure source; and an outlet through which gas exits the negative pressure source;
a diluent gas source configured to deliver a diluent gas to dilute the therapeutic gas effluent before the therapeutic gas effluent enters through the inlet of the negative pressure source;
wherein the therapeutic gas source comprises oxygen from an oxygen source that includes an oxygen concentrator configured to receive atmospheric air and remove nitrogen from the air; and
wherein the diluent gas comprises the nitrogen removed by the oxygen concentrator.
2. The device of claim 1 , wherein the diluent gas source is integral with the therapeutic gas source.
3. The device of claim 1 , wherein the chamber comprises an oxygen-sorbent material having one or more elements selected from the group of elements consisting of: iron, sodium chloride, and activated carbon.
4. The device claim 1 , wherein the container comprises one or more oxygen filters configured to absorb oxygen, the one or more oxygen filters being impregnated with one or more elements selected from the group of elements consisting of: pyrogallol, iron, silver chloride, and ascorbic acid.
5. The device of claim 1 , where the diluent gas source comprises a reservoir containing the diluent gas, wherein the reservoir is configured to be coupled to the container in fluid communication with the chamber to provide the diluent gas to the chamber.
6. The device of claim 1 , wherein the diluent gas comprises nitrogen.
7. The device of claim 1 , comprising one or more effluent conduits configured to be coupled to the first inlet to permit fluid communication of the therapeutic gas effluent between the dressing and the chamber.
8. The device of claim 7 , comprising one or more first diluent conduits configured to be coupled between the diluent gas source and at least one of the one or more effluent conduits to permit fluid communication of the diluent gas between the diluent gas source and the chamber.
9. The device of claim 1 , comprising one or more second diluent conduits configured to be coupled between the diluent gas source and the container to permit fluid communication of the diluent gas between the diluent gas source and the chamber.
10. The device of claim 1 , comprising:
a second outlet configured to be in fluid communication with the diluent gas source;
one or more third diluent conduits configured to be coupled to the second outlet to permit fluid communication of the diluent gas between the diluent gas source and the dressing.
11. The device of any of claim 1 , comprising one or more fourth diluent conduits configured to be coupled between the diluent gas source and the negative pressure source to permit fluid communication of the diluent gas between the diluent gas source and the negative pressure source.
12. The device of claim 1 , comprising a wound irrigation device configured to provide wound irrigation fluid to the dressing.
13. A device configured to dilute therapeutic gas effluent flowing from a dressing, the device comprising:
a therapeutic gas source configured to provide therapeutic gas to the dressing;
a first outlet configured to be in fluid communication with the therapeutic gas source;
a container comprising a sidewall that defines a chamber configured to receive the therapeutic gas effluent from the dressing;
a first inlet configured to be in fluid communication with the chamber and to receive the therapeutic gas effluent from the dressing;
a negative pressure source configured to be coupled to the container such that the negative pressure source can be activated to draw fluid from the dressing through the chamber of the container, wherein the negative pressure source comprises:
an inlet through which gas is received into the negative pressure source; and an outlet through which gas exits the negative pressure source;
a diluent gas source configured to deliver a diluent gas to dilute the therapeutic gas effluent before the therapeutic gas effluent enters through the inlet of the negative pressure source;
wherein the therapeutic gas source comprises an oxygen source and the therapeutic gas comprises oxygen, and the chamber comprises an oxygen-sorbent material having one or more elements selected from the group of elements consisting of: iron, sodium chloride, and activated carbon.
14. The device of claim 13 , wherein the diluent gas source is integral with the therapeutic gas source.
15. A device configured to dilute therapeutic gas effluent flowing from a dressing, the device comprising:
a therapeutic gas source configured to provide therapeutic gas to the dressing;
a first outlet configured to be in fluid communication with the therapeutic gas source;
a container comprising a sidewall that defines a chamber configured to receive the therapeutic gas effluent from the dressing;
a first inlet configured to be in fluid communication with the chamber and to receive the therapeutic gas effluent from the dressing;
a negative pressure source configured to be coupled to the container such that the negative pressure source can be activated to draw fluid from the dressing through the chamber of the container, wherein the negative pressure source comprises:
an inlet through which gas is received into the negative pressure source; and an outlet through which gas exits the negative pressure source;
a diluent gas source configured to deliver a diluent gas to dilute the therapeutic gas effluent before the therapeutic gas effluent enters through the inlet of the negative pressure source;
wherein the therapeutic gas source comprises an oxygen source and the therapeutic gas comprises oxygen and the container comprises one or more oxygen filters configured to absorb oxygen, the one or more oxygen filters being impregnated with one or more elements selected from the group of elements consisting of: pyrogallol, iron, silver chloride, and ascorbic acid.
16. The device of claim 15 , where the diluent gas source comprises a reservoir containing the diluent gas, wherein the reservoir is configured to be coupled to the container in fluid communication with the chamber to provide the diluent gas to the chamber.